The Central Drugs Standard Control Organization (CDSCO) on December 09, 2024, issued a circular regarding the Shipment of Drug samples sent by foreign National Regulatory Authorities into India for test, examination, or analysis.
All port offices of CDSCO are hereby directed that such drug shipments sent by any NRAs of foreign nations are required to be released on a fast-track basis, subject to the fulfilment of the following conditions-
• The Drug samples shall be sent only by the concerned National Regulatory Authority.
• Drug Samples shall be accompanied by an undertaking stating that the samples have NIL commercial values, and are exclusively used for test, examination, or analysis only.
• The analysis shall be carried out at a testing laboratory possessing valid permission in Form-37.
• The residual samples shall not be returned and shall be disposed of by the testing laboratory as per applicable procedures.
[Circular No. IC/36/2024 (E-office)
